The US Food and Drug Administration (FDA) has granted Alleviant Medical an investigational device exemption (IDE), enabling the company to begin a pivotal trial evaluating its atrial shunt ...

A Gerbode defect is technically a type of ventricular septal defect, although this results in a left ventricular to right atrial shunt. Significant left to right shunting can occur resulting in a ...

An atrial septal defect of the secundum type is ... between the left and right atrium directly causing a left to right shunt. Over time, pulmonary hypertension can develop causing right heart ...

The diagnosis was that of a spontaneous intrahepatic portosystemic venous shunt. Spontaneous intrahepatic portosystemic venous shunts are rare disorders that describe abnormal connections between ...

The global hydrocephalus shunts market was valued at $291.00 million in 2019 and is projected to reach $322.01 million by 2027, registering a CAGR of 2.8% from 2020 to 2027. Growth in the number of ...